
John S. Barbieri
Articles
-
1 month ago |
hcplive.com | John S. Barbieri |Patrick Campbell
The risk of benzene in products containing benzoyl peroxide was a hot topic of discussion in dermatology for 2024, primarily as the result of a report from independent testing company Valisure suggesting the known human carcinogen could form at high levels in many common acne products.1 According to the March 2024 report from Valisure, tests indicated on-market benzoyl peroxide products can form over 800 times the conditionally restricted FDA concentration limit of 2 parts per million for...
-
2 months ago |
jidonline.org | John S. Barbieri |Courtney Rubin |James Pham |Michelle Wong
Keywordsbenzenebenzoyl peroxidesafetyriskcancerWe read with interest the article by Kucera et al. (Kucera et al. 20248. Kucera, K. ∙ Zenzola, N. ∙ Hudspeth, A. ... Evaluation of Benzene Presence and Formation in Benzoyl Peroxide Drug ProductsJ. Invest. Dermatol. 2024;) and agree that this topic is of tremendous importance given the ubiquitous use of benzoyl peroxide (BPO) for acne and other skin conditions.
-
2 months ago |
jamanetwork.com | John S. Barbieri |Courtney Rubin |James Pham |Michelle Wong
The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products Podcast (19:14) 0:00 / 0:00 Although benzoyl peroxide is a foundational acne treatment without a clear alternative,1 there have been concerns about the potential for benzoyl peroxide to break down into benzene, a known human carcinogen.2 Although this issue may not pose a clinically meaningful risk,3-5 it is still important to identify strategies to minimize benzene formation in benzoyl peroxide–containing products....
-
Jan 17, 2025 |
healio.com | Rebecca Forand |Kristen Dowd |John S. Barbieri
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Higher cumulative doses of isotretinoin showed a decreased risk for acne relapse. These findings suggest an individualized approach to care should be implemented.
-
Nov 22, 2024 |
healio.com | Rebecca Forand |Kristen Dowd |John S. Barbieri
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Male and female patients with acne often present and have different skin physiology. Patients treated with triple combination CAB gel experienced similar efficacy and safety, regardless of sex.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →